ReCor Responds to European Society of Hypertension’s (ESH) Updated Guidelines for Management of Arterial Hypertension

ReCor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd., have responded to the European Society of Hypertension's (ESH) updated guidelines for the management of arterial hypertension. The ESH guidelines now endorse renal denervation as a treatment option for patients with resistant or uncontrolled hypertension despite medication use. ReCor Medical has conducted clinical tria..